95 related articles for article (PubMed ID: 15635865)
1. [Multidrug resistance of leukemia cells to cytostatics--the functional fluorescent dye efflux assay evaluated by flow cytometry].
Jankovicová K; Krejsek J; Kopecký O
Vnitr Lek; 2001 Jan; 47(1):25-9. PubMed ID: 15635865
[TBL] [Abstract][Full Text] [Related]
2. Rhodamine 123: is it an appropriate dye to study P-glycoprotein activity in adriamycin-resistant K562 cells?
Denis-Gay M; Petit JM; Ratinaud MH
Anticancer Res; 1995; 15(1):121-6. PubMed ID: 7733620
[TBL] [Abstract][Full Text] [Related]
3. Reversal of P-glycoprotein-mediated multidrug resistance by guggulsterone in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
Xu HB; Li L; Liu GQ
Pharmazie; 2009 Oct; 64(10):660-5. PubMed ID: 19947169
[TBL] [Abstract][Full Text] [Related]
4. Dyes providing increased sensitivity in flow-cytometric dye-efflux assays for multidrug resistance.
Frey T; Yue S; Haugland RP
Cytometry; 1995 Jul; 20(3):218-27. PubMed ID: 7587707
[TBL] [Abstract][Full Text] [Related]
5. [Flow cytometric analysis of P-glycoprotein function by rhodamine 123 dye-efflux assay in human leukemia cells].
Kawabata M; Kobayashi H; Mori S; Sekiguchi S; Takemura Y
Rinsho Byori; 1997 Sep; 45(9):891-8. PubMed ID: 9311264
[TBL] [Abstract][Full Text] [Related]
6. The fluorescent probe Bodipy-FL-verapamil is a substrate for both P-glycoprotein and multidrug resistance-related protein (MRP)-1.
Crivellato E; Candussio L; Rosati AM; Bartoli-Klugmann F; Mallardi F; Decorti G
J Histochem Cytochem; 2002 May; 50(5):731-4. PubMed ID: 11967284
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric functional analysis of multidrug resistance by Fluo-3: a comparison with rhodamine-123.
Koizumi S; Konishi M; Ichihara T; Wada H; Matsukawa H; Goi K; Mizutani S
Eur J Cancer; 1995 Sep; 31A(10):1682-8. PubMed ID: 7488425
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of P-glycoprotein-mediated paclitaxel resistance by reversibly linked quinine homodimers.
Pires MM; Emmert D; Hrycyna CA; Chmielewski J
Mol Pharmacol; 2009 Jan; 75(1):92-100. PubMed ID: 18945821
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporine diminishes multidrug resistance in K562/ADM cells and improves complete remission in patients with acute myeloid leukemia.
Li GY; Liu JZ; Zhang B; Wang LX; Wang CB; Chen SG
Biomed Pharmacother; 2009 Sep; 63(8):566-70. PubMed ID: 19095404
[TBL] [Abstract][Full Text] [Related]
10. DiOC2(3) is not a substrate for multidrug resistance protein (MRP)-mediated drug efflux.
Minderman H; Vanhoefer U; Toth K; Yin MB; Minderman MD; Wrzosek C; Slovak ML; Rustum YM
Cytometry; 1996 Sep; 25(1):14-20. PubMed ID: 8875050
[TBL] [Abstract][Full Text] [Related]
11. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX
Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236
[TBL] [Abstract][Full Text] [Related]
12. [Correlation between reversing effect of cepharanthine hydrochloride on multidrug resistance and P-glycoprotein expression and function of K562/ADR cells].
Peng YM; Wang N; Wang YF; Han L; Zhang Y; Jiang JH; Zhou YB; Wang QD
Yao Xue Xue Bao; 2012 May; 47(5):594-9. PubMed ID: 22812001
[TBL] [Abstract][Full Text] [Related]
13. Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo.
Fang W; Li Y; Cai Y; Kang K; Yan F; Liu G; Huang W
J Pharm Pharmacol; 2007 Dec; 59(12):1649-55. PubMed ID: 18053326
[TBL] [Abstract][Full Text] [Related]
14. Reversal of p-glycoprotein-mediated multidrug resistance by CJX1, an amlodipine derivative, in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
Ji BS; He L; Liu GQ
Life Sci; 2005 Sep; 77(18):2221-32. PubMed ID: 15967469
[TBL] [Abstract][Full Text] [Related]
15. Activity of P-glycoprotein in B-cell chronic lymphocytic leukemia determined by a flow cytometric assay.
Ludescher C; Hilbe W; Eisterer W; Preuss E; Huber C; Gotwald M; Hofmann J; Thaler J
J Natl Cancer Inst; 1993 Nov; 85(21):1751-8. PubMed ID: 8105101
[TBL] [Abstract][Full Text] [Related]
16. Bodipy-FL-verapamil: a fluorescent probe for the study of multidrug resistance proteins.
Rosati A; Candussio L; Crivellato E; Klugmann FB; Giraldi T; Damiani D; Michelutti A; Decorti G
Cell Oncol; 2004; 26(1-2):3-11. PubMed ID: 15371652
[TBL] [Abstract][Full Text] [Related]
17. Differential effect of phenothiazines on MRP1 and P-glycoprotein activity.
Wesołowska O; Molnar J; Ocsovszki I; Michalak K
In Vivo; 2009; 23(6):943-7. PubMed ID: 20023237
[TBL] [Abstract][Full Text] [Related]
18. Modulation of P-glycoprotein-mediated multidrug resistance in K562 leukemic cells by indole-3-carbinol.
Arora A; Seth K; Kalra N; Shukla Y
Toxicol Appl Pharmacol; 2005 Feb; 202(3):237-43. PubMed ID: 15667829
[TBL] [Abstract][Full Text] [Related]
19. The effect of fatty acids and analogues upon intracellular levels of doxorubicin in cells displaying P-glycoprotein mediated multidrug resistance.
Abulrob AN; Mason M; Bryce R; Gumbleton M
J Drug Target; 2000; 8(4):247-56. PubMed ID: 11144235
[TBL] [Abstract][Full Text] [Related]
20. Lamellarin D: a novel pro-apoptotic agent from marine origin insensitive to P-glycoprotein-mediated drug efflux.
Vanhuyse M; Kluza J; Tardy C; Otero G; Cuevas C; Bailly C; Lansiaux A
Cancer Lett; 2005 Apr; 221(2):165-75. PubMed ID: 15808402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
